Citation: Tchernev G, Lotti T, Wollina U, Cardoso JC, Popova LV, Maximov GK, Lozev I, Terziev I. Sarcoidosis in A. C. Milan (1899) 
Introduction
At the current stage of knowledge the definition of sarcoidosis as an autonomous disease, as well as the differentiation between sarcoidosis and sarcoid -type reactions, remain unclear and a serious clinical and diagnostic challenge [1] .
An accurate distinction between these two concepts is crucial because it presumes completely different clinical behaviour and therapeutic strategies [2] . On the other hand, it is a very serious question whether the term sarcoidosis has to be reconsidered as a non-autonomous disease but rather as a reaction pattern [3] .
We present an interesting patient with histopathologically -proven sarcoid granulomas and discuss the possible pathogenetic relationship between the disturbance of tissue homeostasis and granuloma formation. _______________________________________________________________________________________________________________________________ 
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Case report section

Anamnesis
A 42 -year -old male patient presented to the department of dermatologic surgery due to a rash on his right tight. Pruritus leading to scratching and bleeding was reported as a subjective complaint. The symptoms occurred one year and a half after performing a tattoo with the logo of the football team AC Milan (1899). The patient noticed thickening of the skin under the blazon, exactly in the area of the red pigment, which had started to disappear (Fig.1 a) . The patient had histologically proven cutaneous sarcoidosis from 03/2014. Therapy with methylprednisolone 60mg/day, with gradual tapering of the dose, was started. In 02/2015 systemic sarcoidosis was additionally proved histologically after a biopsy of endobronchial granulations. Throughout several months, dermatologic and pulmonary consultations were performed as well as control CT and chest radiography. Meanwhile, the dosage of methylprednisolone was slowly reduced or increased according to disease fluctuations. According to the more recent data, methylprednisolone was prescribed in the following doses In 09/2016, treatment with methotrexate at a dose of 20 mg weekly was prescribed for six months, followed by reduction of the dose to 10 mg weekly until 09/2017 when the treatment was suspended. By the regular follow-up tests, the treatment mentioned above was considered inefficient.
QuantiFERON test and serological tests (anti-HCV and HBsAg) were negative.
Physical examination
Disseminated annular lesions with the atrophic centre and raised edges, well demarcated from the surrounded skin were observed on the scalp, face, trunk and upper limbs ( Fig.1 b, c, d ). Enlarged inguinal lymph nodes were identified by palpation.
Ancillary tests
Laboratory tests revealed elevated ESR -18 mm/h (< 11 mm/h); WBC -31.0/l (3.5 -10.5/l); Crystal -9.0/l (-); Plasma uric acid -526.0 mol/l (< 410 mol/l). Microbiological analysis of a skin swab identified S. aureus, sensitive to amoxicillin, cefuroxime, ciprofloxacin and clindamycin. Chest radiography detected bilateral hilar enlargement with irregular borders, consistent with hilar lymphadenopathy (Fig. 2 ). An infiltrate with perihilar paracardial localisation could not be excluded. Horizontal linear opacities between the medium and lower lobes of the right lung were also reported ( Fig. 3) . 
Treatment and outcome
To eradicate the infectious process he underwent treatment with ciprofloxacin 100mg 2 x 2/d i.v. and local dressings with Jodasept® unguent, resulting in successful results.
The patient was diagnosed with skin and systemic sarcoidosis. According to the clinical consultations he performed, treatment was inefficient and did not lead to any significant improvement of the pulmonary changes. Furthermore, the progression of the cutaneous lesions of sarcoidosis was observed.
Therefore
Discussion
Once more, we focus the attention of our colleaguеs and the dermatologic community on the pathogenesis of sarcoidosis, still defined as an "autonomous disease", a concept that, in our opinion, should be reconsidered. A sarcoid granuloma is not equivalent to the disease sarcoidosis because it is observed as a result of 1) possible paraneoplastic manifestation, resulting from cross-reaction between antigens of the self and cancer antigens; 2) reaction pattern (cross-mediated or direct immunity) against several microbiological agents [1] . Is sarcoidosis such a wide-spectrum disease?
One of the difficulties in distinguishing sarcoidosis as an autonomous disease from sarcoidal-type reactions comes from their main common feature, which is the presence of epithelioid cell granulomas [3] . However, there is no "gold standard" for systematic diagnostic approach and prediction of clinical behaviour in cases of histologically proven epithelioid cell granulomas [4] . The definition of sarcoidosis states that it is a disease characterised by the presence of non -caseating epithelioid cell granulomas in several organs and tissues [5] . By definition, granulomas in sarcoidosis are sterile, so the presence of any identifiable immunogenic triggering agents makes it more accurate to refer to this reaction as a sarcoidal type of reaction pattern [6] [7] . In our opinion, sterile sarcoid granuloma should not equate to sarcoidosis disease. [14] . Our concepts of sarcoid -type reaction are based on the assumption that it may be provoked, in predisposed patients, by cross-reaction to immunogens or tumour antigens, so its pathogenesis is closely related to the generation of cross -mediated immunity presenting as molecular (antigen) mimicry. This phenomenon occurs by the similarity between certain amino acid sequences in the triggering antigens and molecular structures in the body [15] . The precise distinction between these two terms is extremely important because misdiagnosis may lead to the introduction of inappropriate treatment. Immunosuppressive therapy, which is recommended as first-line treatment for sarcoidosis, can enhance a tumour or infectious progression in patients afflicted by those conditions, with all its deleterious consequences for the patient [16] [17] [18] .
Blau syndrome (BS), for example, is a rare autosomal dominant autoinflammatory disease characterised by the clinical triad of dermatitis, arthritis, and uveitis. It is caused by mutations in nucleotide-binding oligomerisation domain-containing protein -2 (NOD2) gene [19] . It is unclear whether and to what extent this autoinflammatory syndrome overlaps with congenital or early-onset sarcoidosis, which is most probably genetically determined [20] . It is a somewhat disturbing fact that the mechanism of granuloma formation in these patients is completely different from the one that originates similar types of granulomas in patients with certain forms of cancer or deep mycosis. Sarcoid granulomas are obviously the final result of diverse pathogenic mechanisms, which are, in turn, activated by different specific diseases [1] [21] .
Would it be accurate to define existing sarcoidosis as a disease occurring by 1) congenital genetic defect; 2) paraneoplastic reaction; 3) parainfectious or infectious disease, as well as the incorporation of inorganic material via inhalation or skin contact? According to our observations, sarcoid-like reactions could be determined by the capability of the organism (or a genetically determined predisposition) for reacting against different kinds of antigens. These antigens could be either exogenously incorporated into the body or generated by the tissue homeostasis (de novo) as seen in the process of carcinogenesis. This abnormality of tissue homeostasis is the main trigger of sarcoid-like reactions [22] . Thus, clinicians should be cautious in the approach to this kind of reactions. In case of a histological diagnosis of sarcoid granulomas, it is of great importance to exclude: 1) different forms of tumours; 2) infectious _______________________________________________________________________________________________________________________________ 102 https://www.id-press.eu/mjms/index diseases with diverse origin. Following the standard definition of sarcoidosis and starting immunosuppressive therapy may lead to a significant risk of potentiating cancer progression or worsening of an underlying infection, which may have fatal consequences, as we already unravelled.
In conclusion, we consider the present case of a patient with a sarcoid-like reaction secondary to a tattoo, as an illustrative example of our theory of antigen mimicry as the mechanism leading to granuloma formation in genetically predisposed individuals. The persistence of symptoms in spite of treatment with corticosteroids followed by methotrexate in combination with corticosteroids is not unique in the setting of sarcoidosis or sarcoid type reactions. In such patients, we hypothesise that it is of vital importance to eliminate the trigger of molecular mimicry, which may potentially lead to normalization of the tissue homeostasis and the immune response.
It remains an open question: Sarcoidosis -does it exist?
